Discover 3,049 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,049
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
for
Relapsed/Refractory Follicular Lymphoma,
Location: Los Angeles CA, Hattiesburg MS, Waukesha WI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06149286
Phase 3, Recruiting
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Dallas TX
Sponsor: 1200 Pharma, LLC
Sex: All
Age: 18+
Code: NCT05103046
Phase 1, Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
for
Colorectal Adenocarcinoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06225011
Phase 1, Recruiting
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)
for
Lupus Erythematosus, Systemic
Location: Los Angeles CA, Charlotte NC, Manhasset NY
Sponsor: Ampel BioSolutions, LLC
Sex: All
Age: 18+
Code: NCT05845593
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Los Angeles CA, Santa Clara CA, Oakland CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Duarte CA, Stanford CA, San Francisco CA, Denver CO,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma,